The equity markets are on a 3-week winning streak, which is hard to accept given the quarter still ended in the red. As we enter the last month of the “Best Six Months” to own stocks, the market logged its first down quarter in 2 years, since the beginning of the pandemic. Going back to 1930, Q1 was positive 55…
A Defensive Rally With A Dreaded Yield-Curve Inversion
A financial market resource for the every-day investor and trader.
-
Staying The Course Through The Chop & Slop
Seth Golden, , Research Reports, 1
Who could have predicted 🔮 this past Friday’s intraday price action and how the day ultimately concluded? Well, calling...
-
Capital Economics: Soft landings, immaculate disinflation, and US equities
Seth Golden, , Research Reports, 0
A “soft landing” for the economy in the US seems increasingly possible, so we look back at previous similar episodes...
-
Coronavirus Correction
Seth Golden, , Research Reports, 0
The bounce back in markets this past week was quite telegraphed in the historical data we presented in the...
-
Investor Fears Of The Unknown
Seth Golden, , Research Reports, 2
A midterm election cycle and year 2 of a Presidential cycle with rising rates and potentially peak inflation have...
-
Sentiment So Bad As Fed Tightening Regime Begins
Seth Golden, , Research Reports, 0
“If falling 10% in stocks over a couple weeks is too much volatility for you, then being up 25%...
-
RBC Capital Cycle & Trend RoadMap December 2023
Seth Golden, , Research Reports, 0
By Robert Sluymer CMT Equity markets are resolving 2-year trading ranges to the upside – Further upside likely in...
-
Morgan Stanley’s Weekly Warm-up: Riding the Wave into the Holidays
Seth Golden, , Research Reports, 0
The US equity market continues to ride the wave of liquidity and seasonal FOMO. As we approach our bull...
-
Fitbit Will Witness Hardships In 2017 That Pave The Way For Share Price Appreciation
Seth Golden, , Research Reports, 0
Fitbit (FIT) is going to struggle with its metric results in 2017, be they financial or operational. This continues...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00